Company Filing History:
3 out of 109 
2 out of 45 
1 out of 1 Years Active: 2010-2016
I specialize in the sphere of innovations, inventions, inventors, patent attorneys, assignees, and patents. Here is the article about Marcia MacDonald:
Title: Marcia MacDonald - Pioneering Inventor from Vancouver, CA
Introduction: Marcia MacDonald is a distinguished inventor based in Vancouver, Canada, known for his groundbreaking work in developing novel therapeutic nucleic acid compositions and methods for treating lipid disorders. With a portfolio of 6 patents to his name, MacDonald has made significant contributions to the field of medical research and innovation.
Latest Patents:
1. Compositions and methods for silencing apolipoprotein C-III expression: MacDonald's recent patent focuses on therapeutic nucleic acids targeting apolipoprotein C-III gene expression. These compositions offer promising solutions for treating lipid diseases like atherosclerosis and dyslipidemia.
2. Methods for identifying analgesic agents: MacDonald's innovative approach involves identifying mutations in the SCN9A gene, which is linked to Congenital Indifference to Pain. His patent outlines methods using small organic compounds to treat pain and predict the effectiveness of analgesic agents.
Career Highlights: Throughout his career, MacDonald has demonstrated a strong commitment to research and development in the pharmaceutical industry. He has held key positions at leading companies such as Xenon Pharmaceuticals Inc. and Protiva Biotherapeutics, Inc., where his expertise has driven advancements in drug discovery and therapeutic innovation.
Collaborations: MacDonald has collaborated with esteemed professionals in the field, including Mark E. Samuels and Robin Sherrington. These partnerships have been instrumental in advancing his research and expanding the scope of his inventions.
Conclusion: Marcia MacDonald's remarkable contributions to science and medicine underscore his status as a pioneering inventor in the field of nucleic acid therapeutics. His dedication to improving patient care and advancing pharmaceutical innovation continues to inspire future generations of researchers and inventors.